Stefan Wagner, Daniel I. Brierley, Alasdair Leeson-Payne, Wanqing Jiang, Raffaella Chianese, Brian Y.H. Lam, . . . Lora K. Heisler. (2023). Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression. Elsevier.
Chicago Style (17th ed.) CitationStefan Wagner, et al. Obesity Medication Lorcaserin Activates Brainstem GLP-1 Neurons to Reduce Food Intake and Augments GLP-1 Receptor Agonist Induced Appetite Suppression. Elsevier, 2023.
MLA (9th ed.) CitationStefan Wagner, et al. Obesity Medication Lorcaserin Activates Brainstem GLP-1 Neurons to Reduce Food Intake and Augments GLP-1 Receptor Agonist Induced Appetite Suppression. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.